Evidence map›Paper›PMID 8133912›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology1993

Evans blue blocks P2X-purinoceptors in rat vas deferens.

R Bültmann, K Starke

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 40 citations in OpenAlex.

  1. ATP: The crucial component of secretory vesicles.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  2. Article
  3. Article
  4. De novo expression of connexin hemichannels in denervated fast skeletal muscles leads to atrophy.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. New insights on P2X purinoceptors.Naunyn-Schmiedeberg's archives of pharmacology · 1995
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

R BültmannPharmakologisches Institut, Universität Freiburg, Germany.
K Starke
University of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In rat vas deferens, Evans blue 100 microM increased contractions elicited by high K+ and by noradrenaline but markedly reduced contractions elicited by the P2X-purinoceptor-selective agonist alpha,beta-methylene ATP (3 microM). The concentration-response curve of alpha,beta-methylene ATP was shifted to the right by Evans blue 30 microM and the maximal contraction was increased. In tissues incubated with nifedipine 10 microM, Evans blue 100 microM tended to increase the residual contraction elicited by noradrenaline and abolished the residual response to alpha, beta-methylene ATP (3 microM). The concentration-response curve of alpha,beta-methylene ATP was progressively shifted to the right by increasing concentrations of Evans blue in the presence of nifedipine; maximal contractions were increased by Evans blue 10 and 30 but not 100 microM. From the shifts to the right caused by Evans blue 30 microM, apparent pKB values of 5.9 (no nifedipine) and 6.0 (nifedipine present) were calculated. It is concluded that Evans blue blocks P2X-purinoceptors in rat vas deferens and in addition causes a non-receptor-specific enhancement of contractions.

Indexed as

Purinergic P2 Receptor AntagonistsAdenosine TriphosphateAnimalsEvans BlueIn Vitro TechniquesMaleMuscle ContractionMuscle, SmoothNifedipineNorepinephrinePotassiumRatsRats, WistarSuraminVas DeferensAdenosine Triphosphatealpha,beta-methyleneadenosine 5'-triphosphateEvans BlueNifedipineNorepinephrinePotassiumPurinergic P2 Receptor AntagonistsSuramin

Identifiers

PMID8133912
OpenAlexW2023647620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.